A Pharmacist Intervention to Improve Mother and Child Health
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- University of Iowa
- Study ID
- NCT06073054
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- Research Pharmacist — BEHAVIORALThe goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
Study Details
The goal of this clinical trial is to learn if a research pharmacist can improve the health of new mothers and their babies. The main questions it aims to answer are: * Will postpartum women who had elevated blood pressure during pregnancy be willing to participate in the study, talk to a pharmacist about their health and the health of their child, and text us their blood pressure measurements? * Will contact with the pharmacist improve the health of the mother and/or the child? Participants will: * complete a baseline demographic survey, * be given a blood pressure cuff and taught how to use it, * be asked to text us their blood pressure values 2 times per day for 7 days after enrollment, * complete a phone call with a pharmacist discussing their health and the health of their baby, * text us their blood pressure 1 time per day for 3 days 1 month after enrollment, * have a 1 month follow-up phone call with the research pharmacist, and * complete an exit survey to provide feedback about the study.
Key Dates
- Start date
- Jan 30, 2024
- Status verified
- Aug 2025
- Primary completion
- Jul 10, 2024
- Completion
- Jul 10, 2024
Study Design
- Enrollment
- 25 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Experimental: Research Pharmacist MonitoringThe pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Primary Outcome Measure
Number of Participants Who Talk to Research Pharmacist [ Time Frame: Through study completion, an average of 30 days ]
Locations (1)
| Facility | City | State | ZIP |
|---|---|---|---|
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 |
Find similar trials in Iowa City, IA
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0Enrolling By Invitation · Indiana University · Birmingham, Alabama
- SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic DiseasesRecruiting · Korey Kennelty · Iowa City, Iowa